
Asia Pacific Cough Drops Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.
No. of Pages: 150 | Report Code: BMIRE00032011 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIRE00032011 | Category: Life Sciences
The Asia Pacific cough drops market size is expected to reach US$ 1,268.96 million by 2031 from US$ 758.74 million in 2023. The market is estimated to record a CAGR of 6.6% from 2023 to 2031.
The Asia Pacific cough drops market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The cough drops market in Asia is steadily expanding due to cultural preferences, environmental factors, and changing consumer behavior. Seasonal illnesses and air quality concerns drive demand in countries like China, India, and Japan. Consumers often prefer herbal remedies with ingredients like ginger and honey, reflecting a trend towards natural wellness. Local manufacturers remain competitive against global brands by aligning with regional tastes. E-commerce has made these products more accessible, and increased focus on respiratory health post-COVID-19 has boosted interest in immunity-supporting lozenges. As health awareness grows, the market is expected to continue its upward trajectory.
Asia Pacific Cough Drops Market Strategic Insights
Asia Pacific Cough Drops Market Segmentation Analysis
Key segments that contributed to the derivation of the Asia Pacific cough drops market analysis are product, application, and distribution channel.
Homemade herbal remedies have been in use for centuries to alleviate coughs and sore throats. With a renewed interest in natural healing practices, many consumers are turning to herbal cough drops, including herbal blends such as thyme or licorice root, as effective alternatives to conventional allopathic options. Consumer awareness about health and wellness is driving the demand for cough drops that contain natural and organic ingredients. People are becoming increasingly aware of the potential side effects of synthetic ingredients incorporated in medications. Thus, there is a growing preference for natural remedies that contain herbal extracts, organic flavors, and other natural constituents. Products containing ingredients such as honey, ginger, and eucalyptus are becoming increasingly popular due to their throat-soothing properties.
In response to the growing consumer inclination toward natural alternatives, manufacturers have begun investing significant resources in innovation for the development of cough drops with herbal extracts and organic flavors. In September 2023, Ricola announced a launch of cough drops that combine Swiss herbs, appealing to traditional herbal remedy enthusiasts. The global shift toward natural ingredients is not confined to developed markets; emerging economies are also witnessing a significant increase in demand for herbal and natural products. Manufacturers could take advantage of this trend by expanding their distribution networks into areas where natural remedies are culturally favored. Companies such as Dabur in India focus on ayurvedic formulations to meet local preferences for herbal solutions. In May 2022, Vicks announced the launch of Tulsi cough drops in India, emphasizing the convenience of traditional remedies. Known for its range of health benefits, Tulsi is effective in treating coughs and sore throats. Moreover, as consumers become more environmentally conscious, manufacturers that implement sustainable practices in sourcing and packaging can stand out in the market. Utilizing eco-friendly materials and promoting the sustainable sourcing of natural ingredients can strengthen brand loyalty among environmentally aware consumers. Thus, the surging focus on natural ingredients and sustainable packaging is projected to create significant growth opportunities for the cough drops market in the near future.
Based on country, the Asia Pacific cough drops market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2023.
According to an article published in the European Respiratory Society in 2022, in China, Chronic cough was found in 3.6% of Chinese adults, 2.4% of those aged 20–49 years, and 6.0% of those aged 50 years or older. The penetration of cough drops in urban areas is notably higher, attributed to changing consumer lifestyles and the availability of a diverse range of products such as herbal and sugar-free options that cater to varied preferences. E-commerce sales have surged as consumers increasingly turn to online channels for convenience and product variety. The Chinese government's focus on health and wellness, and the rising disposable incomes of people are a few other factors supporting market expansion in the country. Additionally, manufacturers' emphasis on integrating natural ingredients into formulations and using innovative packaging solutions enhances product appeal. The cough drop market in China has seen significant growth, driven by increasing awareness of health and wellness, rising pollution levels, and the prevalence of respiratory ailments.
Asia Pacific Cough Drops Market Report Highlights
Report Attribute
Details
Market size in 2023
US$ 758.74 Million
Market Size by 2031
US$ 1,268.96 Million
CAGR (2023 - 2031) 6.6%
Historical Data
2021-2022
Forecast period
2024-2031
Segments Covered
By Product
By Application
By Distribution Channel
Regions and Countries Covered
Asia Pacific
Market leaders and key company profiles
Asia Pacific Cough Drops Market Company Profiles
Some of the key players operating in the market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The Asia Pacific Cough Drops Market is valued at US$ 758.74 Million in 2023, it is projected to reach US$ 1,268.96 Million by 2031.
As per our report Asia Pacific Cough Drops Market, the market size is valued at US$ 758.74 Million in 2023, projecting it to reach US$ 1,268.96 Million by 2031. This translates to a CAGR of approximately 6.6% during the forecast period.
The Asia Pacific Cough Drops Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cough Drops Market report:
The Asia Pacific Cough Drops Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Cough Drops Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Cough Drops Market value chain can benefit from the information contained in a comprehensive market report.